Therapeutics Supplements and Botanicals
RRM Academy Synopsis
Ginger may lower primary dysmenorrhea pain, pooled trials suggest
A 2015 review of four pooled randomized trials found suggestive evidence that ginger lowered pain scores more than placebo in women with primary dysmenorrhea. That term means painful periods with no structural cause.
Key Findings
- Of 29 articles found across 12 electronic databases, seven were eligible.
- Four of the seven gave ginger or placebo during the first 3-4 days of the cycle, and these were the ones pooled.
- Combining those four, pain on the visual analogue score fell significantly with ginger (risk ratio, -1.85; 95% CI of -2.87, -0.84, P = 0.0003).
- Bias risk ran low to moderate in six of the seven trials.
Interpretation
The review is a meta-analysis of randomized trials. Four trials went into the pooled estimate, and the authors call the evidence suggestive. They report that no earlier review had gathered it. The source here is the published abstract alone, so trial sizes and individual results are not summarized. The review addresses primary dysmenorrhea.
RRM Context
Period pain is a symptom, and restorative reproductive medicine asks what produces it in each woman. Primary dysmenorrhea has no structural cause. Endometriosis is a separate, diagnosable source of cycle pain, and evaluation sorts out which applies.
Abstract
There has been no attempt to date to synthesize the available evidence for the efficacy of ginger for treating primary dysmenorrhea. This systematic review evaluates the current evidence for the effectiveness of ginger for treating primary dysmenorrhea.
Literature searches were conducted using 12 electronic databases including PubMed, EMBASE, Cochrane Library, Korean databases, Chinese medical databases, and Indian scientific database. Search terms used were: "ginger" or "Zingiber officinale" and "dysmenorrhea" and "pain." Studies using ginger as a treatment of primary dysmenorrhea were considered for inclusion. The major outcome of primary dysmenorrhea was assessed using a pain visual analogue score (PVAS).
Initial searches yielded 29 articles. Of these original results, seven met specific selection criteria. Four of the RCTs compared the therapeutic efficacy of ginger with a placebo during the first 3-4 days of the menstrual cycle and were included in the meta analysis. The meta-analysis of these data showed a significant effect of ginger in reducing PVAS in subjects having primary dysmenorrhea (risk ratio, -1.85; 95% CI of -2.87, -0.84, P = 0.0003). Six RCTs out of 7 exhibited low to moderate of risk of bias.
Collectively these RCTs provide suggestive evidence for the effectiveness of 750-2000 mg ginger powder during the first 3-4 days of menstrual cycle for primary dysmenorrhea.
Topics
Keywords
Dysmenorrhea, Ginger, Pain Visual Analog Scale, Randomized Clinical Trials, Systematic Review


